The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis
- PMID: 1551632
- DOI: 10.1002/hep.1840150403
The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis
Abstract
Before the availability of serological markers for hepatitis C, the morphological features of this diagnosis, which represents most non-A, non-B hepatitis, could not be confirmed. We examined biopsy specimens from 50 patients with chronic hepatitis C and 21 patients with autoimmune chronic hepatitis. Each biopsy specimen was graded on 19 different histological features. The results indicated that at the time of biopsy, the average age of patients with chronic hepatitis C was 46 yr vs. 36 yr for autoimmune chronic hepatitis. Cirrhosis was seen more frequently in autoimmune chronic hepatitis (90%) than in hepatitis C (58%). Features more commonly observed in chronic hepatitis C were bile duct damage (91% vs. 40%), bile duct loss (91% vs. 20%), steatosis (72% vs. 19%) and lymphoid cell aggregation (follicles) within portal tracts (49% vs. 10%). Severe lobular necrosis and inflammation (76% vs. 38%), piecemeal necrosis (81% vs. 10%), multinucleated hepatocytes (29% vs. 6%) and broad areas of parenchymal collapse (76% vs. 6%) were seen more often in autoimmune chronic hepatitis. Exclusion of five patients with autoimmune chronic hepatitis who received immunosuppression before biopsy accentuated these differences. In conclusion, morphological criteria, in addition to serological data, may be useful for differentiating chronic hepatitis C from autoimmune chronic hepatitis, which histologically is a more aggressive disease.
Similar articles
-
Fibrosis and other histological features in chronic hepatitis C virus infection: a statistical model.J Clin Pathol. 1996 Jun;49(6):465-9. doi: 10.1136/jcp.49.6.465. J Clin Pathol. 1996. PMID: 8763259 Free PMC article.
-
Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis.Gastroenterology. 1993 Dec;105(6):1824-32. doi: 10.1016/0016-5085(93)91081-r. Gastroenterology. 1993. PMID: 8253358
-
The pathology of hepatitis C.Hepatology. 1992 Apr;15(4):567-71. doi: 10.1002/hep.1840150402. Hepatology. 1992. PMID: 1551631
-
Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.Minerva Gastroenterol Dietol. 2009 Mar;55(1):53-70. Minerva Gastroenterol Dietol. 2009. PMID: 19212308 Review.
-
[Chronic hepatitis].Verh Dtsch Ges Pathol. 1995;79:171-6. Verh Dtsch Ges Pathol. 1995. PMID: 8600682 Review. German.
Cited by
-
Hepatic steatosis in hepatitis C virus genotype 3 infection: does it correlate with body mass index, fibrosis, and HCV risk factors?Dig Dis Sci. 2004 Jan;49(1):25-9. doi: 10.1023/b:ddas.0000011597.92851.56. Dig Dis Sci. 2004. PMID: 14992430
-
Increase of chemokine interferon-inducible protein-10 (IP-10) in the serum of patients with autoimmune liver diseases and increase of its mRNA expression in hepatocytes.Clin Exp Immunol. 2001 Feb;123(2):271-9. doi: 10.1046/j.1365-2249.2001.01391.x. Clin Exp Immunol. 2001. PMID: 11207658 Free PMC article.
-
Assessment of histological features and outcome of interferon therapy in chronic hepatitis C.J Gastroenterol. 1996 Feb;31(1):69-74. doi: 10.1007/BF01211189. J Gastroenterol. 1996. PMID: 8808431
-
Hepatitis C: progress and problems.Clin Microbiol Rev. 1994 Oct;7(4):505-32. doi: 10.1128/CMR.7.4.505. Clin Microbiol Rev. 1994. PMID: 7834603 Free PMC article. Review.
-
Human subtilase SKI-1/S1P is a master regulator of the HCV Lifecycle and a potential host cell target for developing indirect-acting antiviral agents.PLoS Pathog. 2012 Jan;8(1):e1002468. doi: 10.1371/journal.ppat.1002468. Epub 2012 Jan 5. PLoS Pathog. 2012. PMID: 22241994 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical